EUDA Health Holdings Ltd EUDAW

Q1 FY2023 · ended Mar 31, 2023 · Revenue $1.70M · Filed Jul 31, 2023

EUDA Health Holdings Ltd (EUDA) files with the SEC under industry code 8000, Services-Health Services. In Q1 of fiscal 2023, the quarter ended Mar 31, 2023, it reported revenue of $1.7 million and a net loss of $2.4 million. As of Dec 31, 2025 it held $345,145 in cash and investments and $200,698 in total debt.

Revenue
$1.70M
Net income
$-2.41M
-5196.8% vs year-ago quarter
Operating cash flow
$-469,908
-279.6% vs year-ago quarter
Free cash flow
—
EPS
$-0.12
Dividend per share
None
Shares outstanding
1.89M
-94.9% vs year-ago quarter
Net cash
$144,447
Q4 FY2025
Operating margin
-116.4%
Q1 FY2023

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
EUDA (Nasdaq), EUDAW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Virgin Islands, British
Headquarters
Eunos Techpark
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1847846
Former names
8i Acquisition 2 Corp. (until Nov 17, 2022)

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q1 FY2023
Mar 31, 2023
Q4 FY2022
Dec 31, 2022
Q3 FY2022
Apr 30, 2022
Q2 FY2022
Jan 31, 2022
Q1 FY2022
Oct 31, 2021
Revenue
$1.7M
—
—
—
—
Operating income
-$2.0M
-$11.5M
-$481,638
-$225,636
—
Net income
-$2.4M
-$24.1M
-$472,989
-$224,890
-$45,587
Diluted EPS
-$0.12
—
—
—
—
Operating cash flow
-$469,908
-$873,940
-$540,543
$11,455
—
Total assets
$25.5M
$25.6M
$86.9M
—
—
Total liabilities
$31.4M
$29.1M
$3.9M
—
—
Stockholders' equity
-$6.0M
-$3.5M
-$2.5M
—
—
Cash and investments
—
—
$546,887
—
—
Total debt
$201,323
$102,160
—
—
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 3, 2026 Oct 31, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Sep 29, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 26, 2026 Aug 26, 2026
6-K Current report (foreign issuer) Jul 31, 2026 Jul 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.